Introduction
Inflammation and brain health are tied together far more tightly than most people realize. Your immune system does not stop at the neck. The same signaling molecules that answer a cut or an infection also reach the brain. When that response stays switched on for years, it changes how nerve cells communicate. This article explains what inflammation actually is, how it reaches the brain, and what large human studies have measured. You will learn which daily inputs move inflammatory markers and where the evidence stops. I will close with what my own clinical research measured, limits stated plainly.
Inflammation and Brain Health Begin With a Normal Immune Response
Inflammation is not the enemy. Inflammation is the immune system doing its job. When you cut your hand, immune cells rush to the site, clear debris, and rebuild tissue. That response is acute, useful, and self-limiting. It arrives, it works, and it shuts down.
Cytokines (i.e., small signaling proteins that immune cells use to talk to one another) coordinate the whole process. Interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α) are two of the best studied. C-reactive protein (CRP) is made by the liver in response to those signals. Clinicians measure it as a general marker of inflammatory activity.
The problem begins when the response never fully shuts down. Chronic low-grade inflammation is sterile, meaning no infection drives it. Franceschi and colleagues named this state inflammaging in their review of age-related disease (Franceschi et al., 2018). They described it as a persistent, low-level inflammatory tone that develops with age. Cell debris, misplaced molecules, nutrients, and the gut microbiota all help sustain it.
Your brain is unusually exposed to that state. It consumes roughly a fifth of your resting energy while making up about two percent of your body weight. Neurons also replace themselves poorly compared with skin or gut lining. A tissue burning that much fuel with that little repair capacity has small margin for years of immune activation.
Neuroinflammation: The Brain Runs Its Own Immune System
Neuroinflammation describes the immune response that happens inside the central nervous system itself. The brain does not rely on circulating white blood cells for routine defense. It keeps its own resident immune cells instead.
Microglia are the primary ones. Kwon and Koh reviewed the evidence and described microglia as the resident immune cells of the brain (Kwon & Koh, 2020). Astrocytes (i.e., star-shaped support cells that maintain the chemical environment around neurons) act as the second major player. Their review draws on both animal and human work. I therefore read the mechanistic detail as a hypothesis about people rather than settled fact.
In their healthy state, microglia prune unused connections and clear cellular waste. Under sustained activation, the same cells release inflammatory cytokines into brain tissue. Kwon and Koh describe that shift as a central feature of neurodegenerative disease in their review.
The blood-brain barrier sits between the two systems. It is a selective lining of blood vessels controlling what crosses from circulation into brain tissue. Peripheral inflammation appears to weaken that lining over time. A weakened barrier is the most plausible route by which inflammation and brain health become the same conversation. I want to be careful here because much of the barrier work comes from animal models rather than from people.
Neuroinflammation also carries no pain signal. Your brain has no pain receptors of its own, so nothing tells you it is happening. That silence is exactly why the measurable markers in blood matter so much.
Inflammatory Markers and Cognition: What Large Human Studies Measured
Let me state the limits before the findings. The studies below are observational cohorts, not randomized trials. They can show that two things travel together. They cannot prove that one causes the other. Reverse causation remains possible, meaning early brain changes could raise inflammatory markers rather than the opposite.
With that said, the size and length of this work deserve real weight. In the Whitehall II cohort, 5,217 midlife British civil servants had IL-6 and CRP measured (Singh-Manoux et al., 2014). Those adults then completed cognitive testing across ten years. Participants in the high IL-6 group showed greater ten-year decline in reasoning than the low IL-6 group. Their odds of a meaningful drop on the Mini-Mental State Examination were 1.81 times higher.
One result in that study matters as much as the positive ones. CRP was not associated with decline on any test in those midlife adults (Singh-Manoux et al., 2014). CRP is the marker most people can order cheaply, and in this cohort it predicted nothing. Any company telling you to track a single number is skipping past that inconvenience.
The ARIC study followed a larger group for twice as long. More than 12,000 American adults had five inflammatory markers measured in midlife (Walker et al., 2019). Those adults completed cognitive testing over roughly twenty years. Participants in the highest quartile of the inflammation composite showed 7.8 percent steeper decline than the lowest quartile. Memory declined most consistently across the cognitive domains tested.
Taken together, the link between inflammatory markers and cognition looks real, modest, and slow. A 7.8 percent difference in decline over twenty years is not a cliff. Inflammation and brain health move in the direction you would expect. The size of that relationship argues for patience rather than panic.
Chronic Inflammation and Memory: Anti-Inflammatory Foods for the Brain
Diet is the input you control one or more times a day. Researchers score its inflammatory potential using the Dietary Inflammatory Index. That scale rates a diet from anti-inflammatory to pro-inflammatory (i.e., based on how its components track with measured inflammatory markers).
The most useful test of that score came out recently. Investigators followed 1,487 adults in the Framingham Heart Study Offspring cohort for a median of 13.1 years (Lent et al., 2025). Mean age at entry was 69 years. Higher Dietary Inflammatory Index scores were associated with higher incidence of all-cause dementia in those older adults. The hazard ratio was 1.21 after adjustment for demographic, lifestyle, and clinical factors.
The same limit applies here. Diet in that cohort was captured by food frequency questionnaires, which depend on what participants remembered eating. The authors averaged scores across up to three timepoints to reduce that problem, and they called for replication. I would read the finding as encouraging rather than as proof.
The foods that score well are not exotic. Vegetables, fruit, legumes, whole grains, nuts, seeds, olive oil, tea, and culinary spices all push the score down. Refined carbohydrate, processed meat, and industrially produced fats push it up. Anti-inflammatory foods for the brain are, for the most part, simply whole plant foods eaten in quantity. This is a big reason why I have eaten this way for the last 27 years of my life.
Several compounds in that pattern carry their own literature. Anthocyanins give tart cherry its color and have been studied for their antioxidant behavior. Golden flaxseed supplies alpha-linolenic acid and lignans. Aloe polysaccharides and inositol hexaphosphate have both been examined for their effects on immune signaling. I chose several of these for Daily Brain Care for exactly those reasons.
Chronic inflammation and memory are connected through ordinary meals more than through any capsule. No supplement rescues a diet built on refined food. I made the same argument in my review of the best supplements for memory loss, and I will keep making it.
Exercise, Sleep, and the Other Levers That Move Inflammatory Markers
Physical activity carries the strongest experimental evidence of any lifestyle input here because researchers can randomize it. Zheng and colleagues pooled 11 randomized controlled trials covering 1,250 healthy middle-aged and older adults (Zheng et al., 2019). Regular aerobic exercise lowered CRP, TNF-α, and IL-6 in that pooled analysis.
Randomization is what separates that finding from the cohort work above. Participants did not choose their group, so the usual objection about healthier people simply behaving better does not apply. Exercise moved the markers.
Sleep belongs in the same conversation. Short and fragmented sleep is associated with higher inflammatory markers in adults, and sleep is when the brain clears metabolic waste most efficiently. Body composition matters as well, since fat tissue is metabolically active and secretes inflammatory signals of its own.
Oxidative stress and inflammation feed each other in a loop. Your antioxidant defenses weaken with age, which is the reason I devoted a full article to how to increase glutathione naturally. Environmental exposure belongs in any honest account of inflammation and brain health. I covered that ground in my article on what heavy metals are and where they come from. Signaling proteins shift alongside all of this, including brain-derived neurotrophic factor.
Smoking, chronic psychological stress, untreated gum disease, and heavy alcohol intake each are associated with higher inflammatory markers in adults. None of that is glamorous advice. All of it is better supported than most of what gets sold for the same purpose.
Inflammation and Brain Health in My Own Clinical Research
I will give you the limits first, because they are substantial. My Alzheimer's trial was open-label, meaning everyone knew what they were taking. It carried no placebo group. The sample was small. The participants were adults with moderate-to-severe Alzheimer's disease, not healthy adults, so nothing in it describes a healthy brain.
Here is what we measured. We enrolled adults living with moderate-to-severe Alzheimer's disease and gave them an aloe polymannose multinutrient complex for one year (Lewis et al., 2013). Cytokines were assessed at baseline and at 12 months. Participants showed significant decreases in TNF-α, vascular endothelial growth factor, and interleukins-2 and -4. On the ADAS-cog scale, mean cognition scores improved clinically and statistically significantly by 9 months and again by 12 months. Nearly half of that sample, 46 percent, reached a clinically meaningful change.
A follow-up analysis looked at how immune signaling balanced out among those same participants. At baseline, Th1/Th2 cytokine ratios ran significantly higher in those adults with moderate-to-severe Alzheimer's disease than in healthy controls (Lewis et al., 2023). Five of the six ratios decreased over 12 months. Several of those changes tracked with changes on the cognitive assessments.
Precision matters here more than enthusiasm. Those numbers describe what we observed in a small group of people with a diagnosed disease over one year. Daily Brain Care remains a dietary supplement. It is not a treatment for Alzheimer's disease or for any other condition. Federal law is clear that no supplement may be presented that way.
What the work does support is a formulation logic. We put the whole formula through the trial, not one ingredient in isolation. Whole-food polysaccharides joined plant compounds studied for their behavior in immune signaling. That standard is the reason I was willing to attach my own name to Daily Brain Care. My full academic and research background sits on my about page.
Conclusion
Inflammation and brain health move together slowly, across decades, in directions the large human cohorts have now mapped reasonably well. IL-6 predicted cognitive decline in midlife adults where CRP did not. Diet, exercise, sleep, and body composition all move these markers, and exercise does so under randomization. No supplement substitutes for any of that. Build the foundation first, then choose a formula whose ingredients were studied rather than merely marketed. Give your brain the formula I built on that evidence, and start Daily Brain Care today!
Frequently Asked Questions
What is the connection between inflammation and brain health?
Chronic low-grade inflammation is associated with faster cognitive decline in large human cohorts. Higher midlife IL-6 predicted greater ten-year decline in reasoning in 5,217 midlife adults (Singh-Manoux et al., 2014). These are associations, not proven causes.
What is neuroinflammation?
Neuroinflammation is the immune response occurring inside the central nervous system. Microglia and astrocytes, the brain's resident immune cells, drive it. Sustained activation of those cells releases inflammatory cytokines into brain tissue (Kwon & Koh, 2020).
Which inflammatory marker should I ask my doctor about?
No single marker settles the question. IL-6 predicted cognitive decline in midlife adults in the Whitehall II cohort while CRP did not (Singh-Manoux et al., 2014). Discuss any testing with your physician rather than self-directing it.
Can changing my diet lower inflammation?
Lower Dietary Inflammatory Index scores associated with lower dementia incidence in 1,487 older adults (Lent et al., 2025). Median follow-up ran 13.1 years. Whole plant foods drive that score down.
How long before diet and exercise changes show up in inflammatory markers?
Most exercise trials pooled by Zheng and colleagues ran eight weeks or longer in healthy middle-aged and older adults. Judge nothing in a fortnight. Give any honest change several months.
References
Franceschi, C., Garagnani, P., Parini, P., Giuliani, C., & Santoro, A. (2018). Inflammaging: A new immune–metabolic viewpoint for age-related diseases. Nature Reviews Endocrinology, 14(10), 576–590. https://doi.org/10.1038/s41574-018-0059-4
Kwon, H. S., & Koh, S. H. (2020). Neuroinflammation in neurodegenerative disorders: The roles of microglia and astrocytes. Translational Neurodegeneration, 9, 42. https://doi.org/10.1186/s40035-020-00221-2
Lent, D. M., Yuan, M., Beavers, D. P., Bhadelia, R. A., Bhatt, D. L., Berry, S. D., Lipsitz, L. A., Kiel, D. P., Seshadri, S., Jacques, P. F., & Shivappa, N. (2025). Association between dietary inflammatory index score and incident dementia. Alzheimer's & Dementia, 21(1), e14390. https://doi.org/10.1002/alz.14390
Lewis, J. E., McDaniel, H. R., Agronin, M. E., Loewenstein, D. A., Riveros, J., Mestre, R., Martinez, M., Colina, N., Abreu, D., Konefal, J., Woolger, J. M., & Ali, K. H. (2013). The effect of an aloe polymannose multinutrient complex on cognitive and immune functioning in Alzheimer's disease. Journal of Alzheimer's Disease, 33(2), 393–406. https://doi.org/10.3233/JAD-2012-121381
Lewis, J. E., McDaniel, H. R., Woolger, J. M., & Khan, S. A. (2023). The characterization of the Th1/Th2 ratio in moderate-severe Alzheimer's disease patients and its response to an aloe polymannose-based dietary supplement. Journal of Alzheimer's Disease, 96(4), 1723–1737. https://doi.org/10.3233/JAD-230659
Singh-Manoux, A., Dugravot, A., Brunner, E., Kumari, M., Shipley, M., Elbaz, A., & Kivimaki, M. (2014). Interleukin-6 and C-reactive protein as predictors of cognitive decline in late midlife. Neurology, 83(6), 486–493. https://doi.org/10.1212/WNL.0000000000000665
Walker, K. A., Gottesman, R. F., Wu, A., Knopman, D. S., Gross, A. L., Mosley, T. H., Selvin, E., & Windham, B. G. (2019). Systemic inflammation during midlife and cognitive change over 20 years: The ARIC Study. Neurology, 92(11), e1256–e1267. https://doi.org/10.1212/WNL.0000000000007094
Zheng, G., Qiu, P., Xia, R., Lin, H., Ye, B., Tao, J., & Chen, L. (2019). Effect of aerobic exercise on inflammatory markers in healthy middle-aged and older adults: A systematic review and meta-analysis of randomized controlled trials. Frontiers in Aging Neuroscience, 11, 98. https://doi.org/10.3389/fnagi.2019.00098
